Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity

Harnessing the immune system for the treatment of non-small-cell lung cancer

Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future

Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients

Vaccine strategies for glioblastoma: progress and future directions

Current status of immunotherapy for the treatment of biliary tract cancer